Empax Centre

Empax Centre is a specialist mental health clinic in Perth, Australia, conducting clinical trials and delivering psychedelic-assisted therapy programs—including MDMA and methylone-assisted therapies—for PTSD, featuring a multidisciplinary approach and rigorous clinical governance. The centre has been selected as a key site for a Phase 2 trial of methylone, an MDMA analogue, for PTSD, and collaborates with Transcend Therapeutics on this study. Empax also offers a comprehensive PTSD care program with psychiatrist-supervised therapy, leveraging real-world data collection and evidence-based practices. Eligible Medibank members can access the program at no out-of-pocket cost, with total treatment typically valued at AUD $20,000–$30,000[1][2][4].